JULIA BRANCH: Open Payments
NPI 1033600341 · CUMMING, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$63,154 in 140 payments from 22 companies in 2025. Trend: 2023 $10,831 · 2024 $24,836 · 2025 $63,154
Speaker / faculty: $28,724Travel & lodging: $17,202Consulting: $14,579Food & beverage: $2,648
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 62 | $37,074 |
| Merck Sharp & Dohme LLC | 18 | $11,047 |
| Janssen Scientific Affairs, LLC | 2 | $6,973 |
| Dendreon Pharmaceuticals LLC | 10 | $6,289 |
| Ferring Pharmaceuticals Inc. | 8 | $693 |
| Sumitomo Pharma America, Inc. | 8 | $275 |
| Tempus AI, Inc | 3 | $175 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $159 |
| PFIZER INC. | 5 | $115 |
| Astellas Pharma US Inc | 2 | $53 |
Products named: RYBREVANT, KEYTRUDA, PROVENGE, ADSTILADRIN, ERLEADA, ORGOVYX, XT CDX, Xtandi.
Industry payments across GA — which companies pay providers there.
